1Rebulla P,Finazzi G,Marangoni F,et al.The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia[J].N Engl J Med,1997,337:1870.
2Wandt H,Frank M,Ehninger G,et al.Safety and cost effectiveness of a 10×10^9/L trigger for prophylactic platelet transfusions compared with the traditional 20×10^9/L trigger:a prospective comparative trial in 105 patients with acute myeloid leukemia[J].Blood,1998,91:3601.
3Kaushansky K,Lok S,Holly RD,et al.Promotion of megakaryocyto progenior expansion and differentiation by the c -Mpl ligand thrombopoietin[J].Nature,1994,369:568 ～ 571.
4Vigon I,Mornon J-P,Cocault L,et al.Molecular cloning and characterization of MPL,the human homolog of the v-mpl oncogene:identification of a member of the hematopoietic growth factor receptor superfamily[J].Proc Natl Acad Sci USA,1992,89,5640 ～5644.
5de Sauvage FJ,Hass PE,Spencer SD,et al.Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand[J].Narure,1994,369:533 ～538.
6Lok S,Kaushansky K,Holly RD,et al.Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo[J].Nature,1994,369:565 ～ 568.
7Bartley TD,Bogenberger J,Hunt P,et al.Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl[J].Cell,1994,77:1117 ～ 1124.
8Sohma Y,Akahori H,Seki N,et al.Molecular cloning and chromosomal localization of the human throbopietin gene[J].FEBS Lett,1004,353:57 ～ 61.
9David J Kuter,C Glenn Begley.Recombinant human thrombopoietin:basic biology and evalution of clinical studies[J].Blood,2002,100 (10):3457 ～ 3469.
10Paul S,Beunett F,Calvetti J,et al.Molecular cloning of a cDNA encoding interleukin-11,a stromal cell-derived lymphopoietic and hematopoietic cytokine[J].Blood,1993,93 (10):467 ～ 472.
2Du X, Williams DA. Interleukin-11: review of molecular,rell biology and clinical use. Blood, 1997; 89:3897- 3908
3Kaviani MD, Mason LE, Bree AG, et al. Effects of recombinant human interleukin 11 on the activation and morphology of peripheral blood platelets and megakaryocytes in nonhuman primates. Blood, 1996(Suppl 1); 88:26a
4Bruno E, Briddell RA, Cooper RJ, et al. Effects of recombinant interleukin 11 on human megakaryocyte progenitor cells. Exp Hematol, 1991; 19:378-381
5Weich NS, Wang A, Fitzgerald M, et al. Recombinant human interleukin-11 directly promotes megakaryocytopoiesis in vitro. Blood, 1997; 90:3893 - 3902
6Tepler I, Elias L, Smith JW, et al. A randomized placedocomtrolled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood, 1996; 87:3607- 3614
7Gordon MS, McCaskill-Stevens WJ, Battiato LA, et al. A phase 1 trial of recombinant human interleukin- 11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood, 1996; 87:3615 - 3624
8Isaacs C, Robert NJ, Bailey FA, et al. Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin. J Clin Oncol, 1997; 15: 3368 -3377
